Literature DB >> 22498194

Impact of FDG-PET on lung cancer delineation for radiotherapy.

Kavita Morarji1, Allan Fowler, Shalini K Vinod, Ivan Ho Shon, Jerome M Laurence.   

Abstract

PURPOSE: The purpose of this study is to assess the impact of fused diagnostic F-18 2-fluoro-2-deoxy-D-glucose (FDG) positron emission tomography (PET)/computed tomography (CT) and planning FDG-PET/CT scans on voluming of lung cancer for radiotherapy.
METHODS: Five radiation oncologists (ROs), five radiation oncology trainees and a radiologist contoured five cases of non-small cell lung cancer. The CT alone, the diagnostic FDG-PET/CT and planning FDG-PET/CT each registered to the CT, were used to contour three volumes. The concordance index (CI) was used to compare each volume with a reference RO.
RESULTS: Although there was considerable inter-observer variability in CT contouring, there was no significant difference between mean volumes of the gross tumour volume for the RO and radiation oncology trainees using any technique. There was no increase in CI with the addition of PET/CT, either diagnostic or planning, for the RO. However, the volumes of the radiation oncology trainees showed a significant increase in CI from 65.8% with CT alone to 68.0% and 72.3% with diagnostic PET/CT and planning PET/CT, respectively (P = 0.028). Mean variation at the tumour/mediastinum interface was significantly reduced with addition of registered PET/CT.
CONCLUSIONS: The concordance of RO with the reference RO did not significantly increase with use of integrated FDG PET/CT images. However, the contouring of radiation oncology trainees' became more concordant with the reference.
© 2012 The Authors. Journal of Medical Imaging and Radiation Oncology © 2012 The Royal Australian and New Zealand College of Radiologists.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22498194     DOI: 10.1111/j.1754-9485.2012.02356.x

Source DB:  PubMed          Journal:  J Med Imaging Radiat Oncol        ISSN: 1754-9477            Impact factor:   1.735


  5 in total

1.  Inter-observer variability of clinical target volume delineation in definitive radiotherapy of neck lymph node metastases from unknown primary. A cooperative study of the Italian Association of Radiotherapy and Clinical Oncology (AIRO) Head and Neck Group.

Authors:  Marianna Trignani; Angela Argenone; Saide Di Biase; Daniela Musio; Anna Merlotti; Stefano Ursino; Ester Orlandi; Domenico Genovesi; Almalina Bacigalupo
Journal:  Radiol Med       Date:  2019-03-09       Impact factor: 3.469

2.  Improving the accuracy and consistency of clinical target volume delineation for rectal cancer by an education program.

Authors:  Yang-Zi Zhang; Xiang-Gao Zhu; Ma-Xiaowei Song; Kai-Ning Yao; Shuai Li; Jian-Hao Geng; Hong-Zhi Wang; Yong-Heng Li; Yong Cai; Wei-Hu Wang
Journal:  World J Gastrointest Oncol       Date:  2022-05-15

3.  PET image segmentation using a Gaussian mixture model and Markov random fields.

Authors:  Thomas Layer; Matthias Blaickner; Barbara Knäusl; Dietmar Georg; Johannes Neuwirth; Richard P Baum; Christiane Schuchardt; Stefan Wiessalla; Gerald Matz
Journal:  EJNMMI Phys       Date:  2015-03-12

4.  Dosimetric Analysis of Microscopic Disease in SBRT for Lung Cancers.

Authors:  Ronghu Mao; Lingling Tian; You Zhang; Lei Ren; Renqi Gao; Fang-Fang Yin; Hong Ge
Journal:  Technol Cancer Res Treat       Date:  2017-10-11

Review 5.  Challenges for Quality Assurance of Target Volume Delineation in Clinical Trials.

Authors:  Amy Tien Yee Chang; Li Tee Tan; Simon Duke; Wai-Tong Ng
Journal:  Front Oncol       Date:  2017-09-25       Impact factor: 6.244

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.